In podocytes, the expression of TGF-β1, thrombospondin-1 (TSP-1), TGF-β type II receptor (TGF-β2R), and phosphorylated Smad2-Smad3 is reported to be substantially increased in FSGS [26]. This evidence concerns the gene SMAD2 and focal segmental glomerulosclerosis.